Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 126.96.36.199. If your access is via an institutional subscription, please contact your librarian to request reinstatement. If you are using a personal subscription, please contact the Duke University Press using the Contact Us form.
Can analysts provide better guidance to policymakers about the valuation of health effects? This paper argues that valuation questions usually cannot be easily sidestepped by the use of cost-effectiveness analysis. Valuations are implicit in the measures of program outcome that we use, as illustrated by an examination of a policy of maximizing discounted quality-adjusted life-years (QALYs). The paper concludes that surveys focused directly on the questions that health and safety policymakers face could be a most fruitful source of guidance.